Skip to main content

Table 1 Mean (and SD) baseline values for all measures for patients who began the trial, all 44 combined and separately for condition assignment, and statistical comparisons among the groups

From: Mindfulness and pharmacological prophylaxis after withdrawal from medication overuse in patients with Chronic Migraine: an effectiveness trial with a one-year follow-up

Variable

Total

(N = 44)

MT-Group

(N = 22)

Med-Group

(N = 22)

t (42)

P

M

SD

M

SD

M

SD

Age

44.5

9.2

45.6

9.3

43.5

9.2

0.75

.457

Age at Onset

20.4

9.0

21.5

10.5

19.3

7.3

0.80

.428

Headache frequency/month

20.5

7.9

19.2

7.8

21.9

7.8

-1.14

.263

Monthly medication intake

18.4

6.5

18.0

6.4

18.8

6.7

-0.41

.681

HIT

66.3

5.2

65.5

5.5

67.1

4.9

-1.05

.301

MIDAS

73.1

39.9

65.3

41.4

81.0

37.6

-1.32

.194

BDI-13

13.3

6.1

13.1

5.8

13.6

6.6

-0.32

.754

STAI-S

48.2

7.3

47.1

6.6

49.4

7.9

-1.06

.297

STAI-T

52.3

9.6

52.1

9.3

52.5

10.0

-0.13

.901